Literature DB >> 9458349

Mitogenic signaling by substance P and bombesin-like neuropeptide receptors in astrocytic/glial brain tumor-derived cell lines.

M Sharif1.   

Abstract

Neuropeptides such as substance P (SP) and bombesin regulate many biological processes through binding to and activating their respective cell surface receptors. Recently, we reported that many astrocytic/glial-derived brain tumor cell lines express functional SP and bombesin receptors (43% and 85%, respectively). Activation of these neuropeptide receptors stimulates several signaling pathways that regulate transcription and translation leading to the induction of mitogenesis in several cell types including astrocytic brain tumor-derived cell lines. We have also shown that a number of signaling pathways are induced by SP and/or bombesin receptors in astrocytic/glial-derived brain tumor cell lines and demonstrated that inhibiting these path-ways by selective compounds such as PD 098059, tamoxifen, CGP 41251, and rapamycin blocks cell growth. In summary, mitogenic signaling by neuropeptides may play a role in brain tumor growth and/or tumor progression, and selective compounds capable of blocking mitogenic signaling have potential to be useful in the treatment of brain tumors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9458349     DOI: 10.3892/ijo.12.2.273

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  4 in total

1.  Conversion to sirolimus immunosuppression in liver transplantation recipients with hepatocellular carcinoma: Report of an initial experience.

Authors:  Jian Zhou; Jia Fan; Zheng Wang; Zhi-Quan Wu; Shuang-Jian Qiu; Xiao-Wu Huang; Yao Yu; Jian Sun; Yong-Sheng Xiao; Yi-Feng He; Yu-Qi Wang; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2006-05-21       Impact factor: 5.742

Review 2.  The emerging role of substance P/neurokinin-1 receptor signaling pathways in growth and development of tumor cells.

Authors:  Hossein Javid; Fariba Mohammadi; Elnaz Zahiri; Seyed Isaac Hashemy
Journal:  J Physiol Biochem       Date:  2019-08-01       Impact factor: 4.158

3.  Anti-tumour activity of tachykinin NK1 receptor antagonists on human glioma U373 MG xenograft.

Authors:  C Palma; M Bigioni; C Irrissuto; F Nardelli; C A Maggi; S Manzini
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

Review 4.  Bombesin Receptor Family Activation and CNS/Neural Tumors: Review of Evidence Supporting Possible Role for Novel Targeted Therapy.

Authors:  Terry W Moody; Lingaku Lee; Irene Ramos-Alvarez; Tatiana Iordanskaia; Samuel A Mantey; Robert T Jensen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-01       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.